Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme

We present the first crystal structures of a human protein bound to analogs of cocaine and heroin. Human carboxylesterase 1 (hCE1) is a broad-spectrum bioscavenger that catalyzes the hydrolysis of heroin and cocaine, and the detoxification of organophosphate chemical weapons, such as sarin, soman and tabun. Crystal structures of the hCE1 glycoprotein in complex with the cocaine analog homatropine and the heroin analog naloxone provide explicit details about narcotic metabolism in humans. The hCE1 active site contains both specific and promiscuous compartments, which enable the enzyme to act on structurally distinct chemicals. A selective surface ligand-binding site regulates the trimer-hexamer equilibrium of hCE1 and allows each hCE1 monomer to bind two narcotic molecules simultaneously. The bioscavenger properties of hCE1 can likely be used to treat both narcotic overdose and chemical weapon exposure.

[1]  K. Chiba,et al.  cDNA cloning, characterization and stable expression of novel human brain carboxylesterase , 1999, FEBS letters.

[2]  S. Alexson,et al.  Involvement of liver carboxylesterases in the in vitro metabolism of lidocaine. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[3]  W. Bosron,et al.  Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. , 1994, Biochemical pharmacology.

[4]  C. Broomfield,et al.  Progress on the road to new nerve agent treatments , 2001, Journal of applied toxicology : JAT.

[5]  S. Kish,et al.  Regional distribution of cocaine in postmortem brain of chronic human cocaine users. , 2000, Journal of forensic sciences.

[6]  M. Redinbo,et al.  Structural insights into CPT-11 activation by mammalian carboxylesterases , 2002, Nature Structural Biology.

[7]  R M Esnouf,et al.  Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. , 1999, Acta crystallographica. Section D, Biological crystallography.

[8]  E. Pennings,et al.  Effects of concurrent use of alcohol and cocaine. , 2002, Addiction.

[9]  A Heine,et al.  Crystal structure of a cocaine-binding antibody. , 2001, Journal of molecular biology.

[10]  J. Cashman,et al.  Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[11]  G. Rose,et al.  Loops in globular proteins: a novel category of secondary structure. , 1986, Science.

[12]  K Hirano,et al.  Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver. , 1997, Biological & pharmaceutical bulletin.

[13]  W. Bosron,et al.  Tissue distribution of cocaine methyl esterase and ethyl transferase activities: correlation with carboxylesterase protein. , 1995, The Journal of pharmacology and experimental therapeutics.

[14]  J Navaza,et al.  Implementation of molecular replacement in AMoRe. , 2001, Acta crystallographica. Section D, Biological crystallography.

[15]  D. M. Maxwell,et al.  Carboxylesterase: specificity and spontaneous reactivation of an endogenous scavenger for organophosphorus compounds , 2001, Journal of applied toxicology : JAT.

[16]  T. Uematsu,et al.  Purification and characterization of guinea-pig liver microsomal deacetylase involved in the deacetylation of the O-glucoside of N-hydroxyacetanilide. , 1997, The Biochemical journal.

[17]  L. Lally.  The CCP 4 Suite — Computer programs for protein crystallography , 1998 .

[18]  Richard A. Lerner,et al.  Crystal structure of a bacterial cocaine esterase , 2002, Nature Structural Biology.

[19]  D. Erie,et al.  A novel single-molecule study to determine protein--protein association constants. , 2001, Journal of the American Chemical Society.

[20]  C. Morton,et al.  Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda, and COS7 cells for recombinant gene expression , 2000, Molecular biotechnology.

[21]  M Hosokawa,et al.  The mammalian carboxylesterases: from molecules to functions. , 1998, Annual review of pharmacology and toxicology.

[22]  P. Houghton,et al.  Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  J Zhang,et al.  Purification and Cloning of a Broad Substrate Specificity Human Liver Carboxylesterase That Catalyzes the Hydrolysis of Cocaine and Heroin* , 1997, The Journal of Biological Chemistry.

[24]  A Helenius,et al.  Setting the standards: quality control in the secretory pathway. , 1999, Science.

[25]  D. Kroetz,et al.  Glycosylation-dependent activity of baculovirus-expressed human liver carboxylesterases: cDNA cloning and characterization of two highly similar enzyme forms. , 1993, Biochemistry.

[26]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[27]  E A Merritt,et al.  Raster3D Version 2.0. A program for photorealistic molecular graphics. , 1994, Acta crystallographica. Section D, Biological crystallography.

[28]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[29]  N. Ariel,et al.  Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. , 2000, Acta crystallographica. Section D, Biological crystallography.

[30]  C. A. Castro,et al.  Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. , 1991, The Journal of pharmacology and experimental therapeutics.

[31]  S. Brimijoin,et al.  Re-engineering butyrylcholinesterase as a cocaine hydrolase. , 2002, Molecular pharmacology.

[32]  B. Tang,et al.  Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver , 2004, European Journal of Clinical Pharmacology.

[33]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[34]  S. Brimijoin,et al.  Cocaine metabolism accelerated by a re-engineered human butyrylcholinesterase. , 2002, The Journal of pharmacology and experimental therapeutics.

[35]  P. Taylor,et al.  Current progress on esterases: from molecular structure to function. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[36]  T. Hurley,et al.  Lessons from a bacterial cocaine esterase , 2002, Nature Structural Biology.

[37]  R. Read.  Improved Fourier Coefficients for Maps Using Phases from Partial Structures with Errors , 1986 .

[38]  W. Bosron,et al.  Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases. , 1996, The Journal of pharmacology and experimental therapeutics.